By Counterforce Health Team in Defitelio (defibrotide) —

How to Get Defitelio (defibrotide) Covered by Humana in California: Prior Authorization Forms, Appeal Process, and Timeline

Quick Answer: Getting Defitelio Covered by Humana in California

Defitelio (defibrotide) requires prior authorization under all Humana Medicare Advantage plans in California. The fastest path to approval: (1) Confirm your plan type via MyHumana portal, (2) Download Humana's 2025 Medicare Prior Authorization form, and (3) Submit with complete medical documentation including HSCT history, bilirubin levels, and ICD-10 code K76.5. Standard decisions take 30 days; expedited reviews available for urgent cases. If denied, California's Independent Medical Review (IMR) has a 68% overturn rate for specialty drug denials.

First step today: Call Humana at 1-800-833-6917 to verify your plan's formulary tier for Defitelio and request the current PA form.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Plan Verification
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Timeline Management
  6. If Additional Information Is Requested
  7. If Your Request Is Denied
  8. California Appeals Process
  9. Renewal and Re-Authorization
  10. FAQ
  11. Quick Reference Checklist

What This Guide Covers

This guide helps patients, families, and healthcare teams navigate Humana's prior authorization process for Defitelio (defibrotide sodium) in California. Defitelio is a specialty IV medication manufactured by Jazz Pharmaceuticals, used to treat severe hepatic veno-occlusive disease (VOD) with renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).

Who this helps:

  • Patients with Humana Medicare Advantage plans in California
  • Caregivers managing prior authorization requests
  • Clinicians preparing medical necessity documentation
  • Those facing denials who need appeal guidance

Before You Start: Plan Verification

Step 1: Confirm Your Humana Plan Type

Medicare Advantage vs. Part D Coverage: Defitelio coverage depends on whether it's classified under Part B (medical benefit) or Part D (pharmacy benefit). Home infusion therapy is typically covered under Part B, while specialty pharmacy dispensing falls under Part D.

Verify your plan: Log into MyHumana portal or call 1-800-833-6917 to confirm:

  • Your specific Medicare Advantage plan name
  • Whether Defitelio is on your plan's formulary
  • Current formulary tier (likely Tier 4 or 5 specialty)
  • Prior authorization requirements

Step 2: Check Formulary Status

Use Humana's Medicare Prescription Drug List tool to search "defibrotide" for your 2025-2026 plan. Note any restrictions like:

  • Step therapy requirements
  • Quantity limits
  • Site of care restrictions

Gather Required Documentation

Medical Documentation Checklist

Essential clinical information:

  • Diagnosis: Hepatic veno-occlusive disease with ICD-10 code K76.5
  • HSCT details: Date of transplant, conditioning regimen, complications
  • Laboratory values: Recent bilirubin levels, liver function tests
  • Prior therapies: Documentation of failed or contraindicated alternatives
  • Severity indicators: Evidence of renal or pulmonary dysfunction

Forms and Administrative Documents

Required forms:

Clinician Corner: Your medical necessity letter should include: (1) Clear diagnosis with ICD-10 K76.5, (2) HSCT history and timeline, (3) Current clinical status with lab values, (4) Why Defitelio is specifically indicated per FDA labeling, and (5) Expected treatment duration and monitoring plan.

Submit Your Prior Authorization Request

Submission Methods

Primary submission route: Access Humana's Medical and Pharmacy Coverage Policies portal to find current Defitelio policy and submission requirements.

Standard process:

  1. Complete all sections of the PA form
  2. Attach medical necessity letter from prescribing physician
  3. Include supporting clinical documentation
  4. Submit via secure fax or provider portal (confirm current method with Humana)

Timeline expectations:

  • Standard review: Up to 30 days for Medicare Advantage
  • Expedited review: 72 hours for urgent situations
  • Part D appeals: 7 days standard, 72 hours expedited

Follow-Up and Timeline Management

When to Follow Up

Day 7: Call to confirm receipt and completeness of your submission Day 15: Check status if no response received Day 25: Escalate if approaching 30-day deadline

Sample phone script: "I'm calling to check the status of prior authorization request [reference number] for Defitelio submitted on [date]. Can you confirm it's under review and provide an expected decision date?"

Documentation During Follow-Up

Keep detailed records of:

  • Reference numbers for all submissions
  • Names and employee IDs of representatives spoken with
  • Dates and times of all communications
  • Any additional information requested

If Additional Information Is Requested

Common requests from Humana:

  • Additional lab values or imaging results
  • Peer-reviewed literature supporting off-label use
  • Documentation of contraindications to alternative therapies
  • Clarification of dosing and administration plan
Important: As of August 2025, Humana requires peer-to-peer reviews to be requested before issuing a denial. Once denied, formal appeals are required.

If Your Request Is Denied

Common Denial Reasons and Solutions

Denial Reason Solution Strategy
Not medically necessary Provide additional clinical evidence, peer-reviewed studies
Step therapy not completed Document contraindications or failures with required alternatives
Off-label use Submit FDA labeling and recognized drug compendia references
Site of care restriction Clarify home infusion vs. facility administration

First-Level Appeal Process

Timeline: You have 65 days from denial notice to file an appeal with Humana.

Required elements:

  • Written appeal letter stating disagreement with denial
  • Additional medical evidence supporting medical necessity
  • Any new clinical information since original request

California Appeals Process

Independent Medical Review (IMR)

California offers robust appeal rights through the Department of Managed Health Care (DMHC). Success rates for specialty drug denials are encouraging: Recent data shows 68.6% of medical necessity denials are overturned in IMR proceedings.

IMR eligibility: Available after internal appeal for denials based on:

  • Medical necessity
  • Experimental/investigational status
  • Emergency or out-of-network services

How to request IMR:

  1. File online at DMHC website or call 1-888-466-2219
  2. Submit within required timeframes (typically after internal appeal)
  3. Include all medical records and physician support letters
  4. No cost to patient - DMHC covers review expenses

Timeline: Standard IMR decisions within 45 days; expedited reviews within 7 days for urgent situations.

From our advocates: We've seen strong IMR success when families include comprehensive medical records, a detailed physician letter explaining why Defitelio is specifically needed for their situation, and peer-reviewed evidence about the drug's effectiveness for severe VOD. The key is painting a complete clinical picture that demonstrates medical necessity.

Renewal and Re-Authorization

Planning ahead: Defitelio authorizations typically require renewal every 6-12 months or per treatment course.

Renewal documentation:

  • Updated clinical status and response to treatment
  • Current laboratory values
  • Continued medical necessity justification
  • Any changes in patient condition or treatment goals

Calendar reminders: Set alerts 30-45 days before authorization expiration to allow adequate processing time.

FAQ

How long does Humana prior authorization take for Defitelio in California? Standard review is up to 30 days for Medicare Advantage plans. Expedited reviews for urgent situations are completed within 72 hours.

What if Defitelio is not on my Humana formulary? You can request a formulary exception through the same prior authorization process. Include medical necessity documentation explaining why formulary alternatives are inappropriate.

Can I request an expedited appeal if denied? Yes, expedited appeals are available for urgent medical situations. Contact Humana immediately if treatment delays could cause serious harm.

Does California's IMR process cost anything? No, Independent Medical Review is free to patients. The DMHC covers all costs associated with the review process.

What counts as medical necessity for Defitelio? Medical necessity typically requires documented severe hepatic VOD following HSCT with renal or pulmonary dysfunction, per FDA-approved labeling and clinical guidelines.

Quick Reference Checklist

Before submitting:

  • Verify Humana plan type and formulary status
  • Obtain current PA form from Humana
  • Gather complete medical records including HSCT history
  • Document lab values (bilirubin, liver function tests)
  • Prepare medical necessity letter with ICD-10 K76.5

During review:

  • Follow up at days 7, 15, and 25
  • Document all communications with reference numbers
  • Respond promptly to requests for additional information

If denied:

  • File internal appeal within 65 days
  • Consider peer-to-peer review if available
  • Prepare for California IMR if internal appeal unsuccessful
  • Contact DMHC Help Center at 1-888-466-2219 for assistance

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals for specialty medications like Defitelio. Our platform helps patients and clinicians navigate complex prior authorization requirements by analyzing denial letters, plan policies, and clinical notes to create point-by-point rebuttals aligned with each payer's specific criteria.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For additional help with insurance appeals in California, contact the DMHC Help Center at 1-888-466-2219 or visit healthhelp.ca.gov.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.